27
total announcements
GKSL.NS · 15 min delayed
Key Stats · Yahoo Finance · as of 20 Oct 2026
Market Cap
₹1,480 Cr
P/E (TTM)
73.9
EPS (TTM)
₹2.54
52W Low
₹98.36
52W High
₹209.80
Dividend Yield
0.00%
Price / Book
4.6
Debt / Equity
11.4
Revenue (TTM)
₹101 Cr
Gross Margin
71.39%
Operating Margin
20.24%
Gujarat Kidney And Super Speciality Limited
Gujarat Kidney And Super Speciality Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018, regarding shares dematerialised during the quarter ended on September 30, 2026.
Gujarat Kidney And Super Speciality Limited
Gujarat Kidney And Super Speciality Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 28, 2026, and informed the Exchange regarding voting results.
Gujarat Kidney And Super Speciality Limited
Gujarat Kidney And Super Speciality Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 28, 2026. The meeting was attended by key managerial personnel, independent directors, and statutory auditors. Resolutions for the financial year ended March 31, 2026, were passed through poll and remote evoting.
Gujarat Kidney And Super Speciality Limited
Gujarat Kidney And Super Speciality Limited has closed its trading window from October 1, 2026, until 48 hours after the declaration of its un-audited financial results for the quarter ending September 30, 2026.
Gujarat Kidney And Super Speciality Limited
Gujarat Kidney And Super Speciality Limited has informed the Exchange about Copy of Newspaper Publication about mailing Annual report
Gujarat Kidney And Super Speciality Limited
Gujarat Kidney And Super Speciality Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 28, 2026
Gujarat Kidney And Super Speciality Limited
Gujarat Kidney And Super Speciality Limited has informed the Exchange about Pre advertisement for Notice of 7th AGM.
Gujarat Kidney And Super Speciality Limited
Gujarat Kidney And Super Speciality Limited has informed the Exchange about attending GIA Healthcare Day with investors/analysts on August 31st, 2026. The meeting will be physical and will refer to publicly available documents for discussions.
Gujarat Kidney And Super Speciality Limited
Gujarat Kidney And Super Speciality Limited has informed the Exchange regarding Outcome of Board Meeting held on August 24, 2026. The Board has appointed Mrs. (Dr) Disha Bharpoda as Additional Non-Executive Independent Director with effect from August 24, 2026. The details as required under Regulation 30 of the Listing Regulations are enclosed as Annexure A.
Gujarat Kidney And Super Speciality Limited
Gujarat Kidney And Super Speciality Limited has informed the Exchange regarding the appointment of Mrs. Disha Bharpoda as an Additional Non-Executive Independent Director, subject to shareholder approval at the next Annual General Meeting.
Gujarat Kidney And Super Speciality Limited
Gujarat Kidney And Super Speciality Limited has informed the Exchange regarding the appointment of Mrs Disha Bharpoda as a Non-Executive Independent Director of the company, effective August 24, 2026.
Gujarat Kidney And Super Speciality Limited
Gujarat Kidney And Super Speciality Limited has announced its unaudited financial results for the quarter ended June 2026, with the independent auditor's review report indicating no material misstatement.
Gujarat Kidney And Super Speciality Limited
Gujarat Kidney And Super Speciality Limited has submitted its unaudited financial results for the quarter ended June 30, 2026, with the independent auditor's review report indicating no material misstatements.
Gujarat Kidney And Super Speciality Limited
Gujarat Kidney And Super Speciality Limited has informed the Exchange about the change in management, appointing Mr. Paresh Dhoti as an Additional Non-Executive Independent Director.
Gujarat Kidney And Super Speciality Limited
Gujarat Kidney And Super Speciality Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32, stating that there was no deviation in the utilization of proceeds of IPO from the objects stated in the Red Herring Prospectus dated December 4, 2025, for the quarter ended June 30, 2026.
Gujarat Kidney And Super Speciality Limited
Gujarat Kidney and Super Speciality Limited has submitted its third Monitoring Agency Report for the quarter ended June 30, 2026, as per SEBI ICDR Regulations, 2018. The report confirms that the funds raised through the Fresh Issue of Equity Shares aggregating to Rs. 250.80 Crore have been utilized for the intended objects of the issue.
Gujarat Kidney And Super Speciality Limited
Gujarat Kidney And Super Speciality Limited has responded to a clarification request from the National Stock Exchange regarding the company's financial results for the quarter ended 30-Sep-2025. The company has paid a penalty for delayed submission of financial results and has corrected discrepancies in the XBRL utility.
Gujarat Kidney And Super Speciality Limited
The NSE has sought clarification from Gujarat Kidney And Super Speciality Limited regarding its financial results for the quarter ended 30-Sep-2025 under Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has been asked to respond to specific queries.
Gujarat Kidney And Super Speciality Limited
Gujarat Kidney And Super Speciality Limited has informed the Exchange regarding Notice of Postal Ballot.
Gujarat Kidney And Super Speciality Limited
Gujarat Kidney And Super Speciality Limited has informed the Exchange regarding the appointment of Mr. Paresh Dhoti as a Non-Executive Non-Independent Director, with the process being completed recently due to technical glitches.